Utility of a New Artificial Dermis as a Successful Tool in Face and Scalp Reconstruction for Skin Cancer: Analysis of the Efficacy, Safety, and Aesthetic Outcomes

Table 1

Preoperative clinical data of the patients who underwent surgery.

ID	Tumor type	Defect size (cm^2)	First operation time (min.)	Second operation time (min.)	Length hospitalization (days)	Healing time (days)	Complications	Follow-up (months)
1	BC	83.7	50	35	1 + 3	45	No	12
2	BC	79.7	45	38	1 + 2	40	No	48
3	SC	65.2	40	32	1 + 2	39	No	40
4	BC	24.7	28	25	1 + 1	37	No	33
5	BC	58.9	40	35	1 + 2	38	No	18
6	BC	45.2	37	38	1 + 2	34	No	23
7	BC	63.7	40	40	1 + 3	37	No	27
8	BC	72.1	44	45	1 + 3	43	No	31
9	MM	16.9	25	25	1 + 1	32	No	43
10	BC	56.2	43	30	1 + 2	39	No	45
11	BC	67.4	45	35	1 + 2	40	No	39
12	SC	32.2	38	30	1 + 1	36	No	19
13	BC	89.5	55	48	1 + 4	45	Partial skin graft necrosis	27
14	BC	78.3	48	37	1 + 3	40	No	37
15	SRC	59.5	40	28	1 + 2	41	No	20
16	SC	53.3	45	26	1 + 2	38	No	19

DM: Diabetes Mellitus, MDT: Multidrug Therapy, S: Smoke.